LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents

Kelly S. ChienDivision of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Caleb A. ClassDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Guillermo Montalban-BravoDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Yue WeiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Koji SasakiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Kiran NaqviDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Irene Ganan-GomezDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Hui YangDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Kelly A. SoltysiakDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Rashmi Kanagal-ShamannaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kim-Anh DoDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Hagop M. KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information

Guillermo Garcia-ManeroDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
View further author information

Articles from other publishers (11)